NDAORALTABLET
Approved
Oct 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
FEMHRT (ethinyl estradiol; norethindrone acetate) by AbbVie is clinical pharmacology endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Approved for women with an intact uterus for the: treatment of moderate to severe vasomotor symptoms associated with the menopause, osteoporosis. First approved in 1999.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FEMHRT is an oral combination hormone replacement therapy (HRT) containing ethinyl estradiol and norethindrone acetate, approved in 1999 for treating moderate to severe vasomotor symptoms (hot flashes) and osteoporosis in postmenopausal women with an intact uterus. The estrogen component binds to nuclear estrogen receptors to reduce elevated gonadotropin levels and vasomotor symptoms, while the progestin opposes estrogen effects on the endometrium to reduce proliferation risk.
LOE Approaching
Product approaching loss of exclusivity with limited commercial visibility; brand team likely focused on generic transition strategy and market defense.
Mechanism of Action
CLINICAL PHARMACOLOGY Endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Although circulating estrogens exist in a dynamic equilibrium of metabolic interconversions, estradiol is the principal…
Worked on FEMHRT at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.